Ildong Holdings Co., Ltd. (KRX:000230)
South Korea · Delayed Price · Currency is KRW 5,890.00
+10.00 (0.17%)
At close: Jul 14, 2026
Ildong Holdings Market Cap
Ildong Holdings has a market cap or net worth of 66.4 billion as of July 14, 2026. Its market cap has decreased by -16.48% in one year.
Market Cap
66.40B
Enterprise Value
365.10B
Revenue
598.69B
Ranking
n/a
PE Ratio
4.32
Stock Price
5,890.00
Market Cap Chart
Since July 12, 1993, Ildong Holdings's market cap has increased from 36.35B to 66.40B, an increase of 82.66%. That is a compound annual growth rate of 1.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 66.40B | -55.76% |
| Dec 30, 2025 | 150.07B | 63.27% |
| Dec 30, 2024 | 91.92B | -22.62% |
| Dec 28, 2023 | 118.79B | -47.79% |
| Dec 29, 2022 | 227.54B | 36.15% |
| Dec 30, 2021 | 167.12B | 6.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyongbo Pharmaceutical | 120.73B |
| SAMSUNG PHARM. Co., LTD. | 116.99B |
| AptaBio Therapeutics | 114.90B |
| HANDOK | 101.33B |
| Jeil Pharma Holdings | 97.94B |
| HLB Pharmaceutical | 86.64B |
| Enzychem Lifesciences | 76.86B |
| CKD Bio | 72.52B |